| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/23/2006 | US20060040262 Novel compositions and methods in cancer |
| 02/23/2006 | US20060039927 Specific binding agents for KSHV vIL-6 that neutralize a biological activity |
| 02/23/2006 | US20060039924 Peptide having modified arginine residue; detecting autoimmune antibodies against rheumatoid arthritis |
| 02/23/2006 | US20060039920 Immunization, scrub typhus of tsutsugamushi disease, HIV |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039915 P-cadherin as a target for anti-cancer therapy |
| 02/23/2006 | US20060039914 Anti-cancer activity of an anti-thymidine kinase monoclonal antibody |
| 02/23/2006 | US20060039913 Monoclonal antibody inhibits ability of monocyte chemoattractant protein (MCP) to cause chemotactic migration to monocytic cells and prevents calcium mobilization; diagnosis and treatment of prostate and colon cancer |
| 02/23/2006 | US20060039912 Antibodies to adipose tissues |
| 02/23/2006 | US20060039909 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 02/23/2006 | US20060039908 cancer associated antigen, transferrin receptor; diagnosing and treating various human cancers and diseases that express transferrin receptor |
| 02/23/2006 | US20060039906 Humanized antibodies that sequester abeta peptide |
| 02/23/2006 | US20060039905 Galectin 11 |
| 02/23/2006 | US20060039904 Erythropoietin-Producing human Hepatocellular (Eph) receptor A2; cancer, inflammatory and autoimmune diseases |
| 02/23/2006 | US20060039901 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/23/2006 | US20060039900 Epitope directed selection of antibodies to murine tissue factor |
| 02/23/2006 | CA2779559A1 Variant fc regions |
| 02/23/2006 | CA2777686A1 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 02/23/2006 | CA2577597A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 02/23/2006 | CA2577183A1 Mutated hiv nef for modulating immunity |
| 02/23/2006 | CA2576886A1 Tie complex binding proteins |
| 02/23/2006 | CA2573192A1 Variant fc regions |
| 02/23/2006 | CA2572671A1 Cytoxan antibodies and immunoassay |
| 02/23/2006 | CA2569235A1 Anti-ghrelin antibodies |
| 02/23/2006 | CA2565961A1 Optimized fc variants |
| 02/22/2006 | EP1627916A1 Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer containing the same |
| 02/22/2006 | EP1627888A1 Antibody and use thereof |
| 02/22/2006 | EP1627886A1 Polypeptide, cDNA encoding the same, and use of them |
| 02/22/2006 | EP1627643A2 Vascular endothelial cell growth factor antagonists |
| 02/22/2006 | EP1627081A2 Use of jag2 expression in diagnosis of plasma cell disorders |
| 02/22/2006 | EP1627067A1 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b |
| 02/22/2006 | EP1627062A1 A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire |
| 02/22/2006 | EP1627046A2 Domain-exchanged binding molecules, methods of use and methods of production |
| 02/22/2006 | EP1627045A2 Pyk2 crystal structure and uses |
| 02/22/2006 | EP1626993A2 Cd20-specific antibodies and methods of employing same |
| 02/22/2006 | EP1626992A1 Production of recombinant igm in per.c6 cells |
| 02/22/2006 | EP1626991A2 Anti alpha-folate-receptor-tetramer antibodies |
| 02/22/2006 | EP1626990A1 Immunotherapy of rectal cancer |
| 02/22/2006 | EP1626989A2 Method of treating corneal transplant rejection by using vegf antagonists |
| 02/22/2006 | EP1626735A2 Compound and method for regulating plasminogen activation and cell migration |
| 02/22/2006 | EP1558741A4 Recombination of nucleic acid library members |
| 02/22/2006 | EP1503781A4 Treatment for weight loss |
| 02/22/2006 | EP1451368A4 Single nucleotide polymorphisms in gh-1 |
| 02/22/2006 | EP1121156B1 Polymer conjugates of interferon beta- 1a and their uses |
| 02/22/2006 | EP1109564B1 Method for removal of hiv and other viruses from blood |
| 02/22/2006 | EP1062336B1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 02/22/2006 | EP1047788B1 Method of determining metastatic potential employing the asp1 gene |
| 02/22/2006 | EP0932682B1 BACILLUS THURINGIENSIS CryET29 COMPOSITIONS TOXIC TO COLEOPTERAN INSECTS AND CTENOCEPHALIDES SPP |
| 02/22/2006 | EP0907378B1 Method for the concentration of antibody solutions |
| 02/22/2006 | EP0814837B2 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 02/22/2006 | EP0805871B2 Anti-cd30 antibodies preventing proteolytic cleavage and release of membrane-bound cd30 antigen |
| 02/22/2006 | CN1739029A Prion protein ligands and methods of use |
| 02/22/2006 | CN1738900A Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/22/2006 | CN1738898A Antimicrobial activity of antibodies producing reactive oxygen species |
| 02/22/2006 | CN1738834A Hcv 疫苗 Hcv vaccine |
| 02/22/2006 | CN1738833A Hcv疫苗 Hcv vaccine |
| 02/22/2006 | CN1738646A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection |
| 02/22/2006 | CN1738643A Composition and method for preventing or treating a virus infection |
| 02/22/2006 | CN1737146A Fuse protein of specific antibody N1M1 and N2M2 and its coding gene |
| 02/22/2006 | CN1737141A Landrace fatness candidate gene SOCS-3 sequence and its uses |
| 02/22/2006 | CN1737133A High purity venom fibrinolysin prepartion method and its pharmaceutical formulation |
| 02/22/2006 | CN1737011A Lymphoma specific chimeric monoclonal antibody against HLA-DR10 |
| 02/22/2006 | CN1243097C Human ICAM-1 extramembranous I-III domain gene expression product ,its prep. and application in radioimmunological technology |
| 02/22/2006 | CN1243021C Interleukin-18 binding proteins, their preparation and use |
| 02/22/2006 | CN1243017C Tumor suppressor, coded protein and application thereof |
| 02/22/2006 | CN1242809C Applications of T-BAM (CD40L) technology in preparation of medicine to treat diseases involving smooth muscle cell |
| 02/21/2006 | US7002001 Modified human C3 protein for forming said convertase; use in depleting levels of complement pathway protein; preventing transplant rejection |
| 02/21/2006 | US7001992 Antibodies to secreted protein HEMCM42 |
| 02/21/2006 | US7001989 Conjugates comprising two active agents |
| 02/21/2006 | US7001985 for controlling activity of cyclin-dependent kinases; treating cancer, immune disorders |
| 02/21/2006 | US7001980 Monoclonal antibodies directed against the G3BP protein, and uses |
| 02/21/2006 | US7001757 Protein |
| 02/21/2006 | US7001734 Process for identifying para cation channel modulators |
| 02/21/2006 | US7001732 RIP3 associated cell cycle protein |
| 02/21/2006 | US7001731 Antibody specific for a chemokine receptor; immunoassay and kits |
| 02/21/2006 | US7001728 Protein of given amino acid sequence which is the product of a gene which shows enhanced expression due to stimulation with TNF alpha; use drug screening; plays an important role in protein protein interactions; drug target |
| 02/21/2006 | US7001599 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/21/2006 | US7001598 Administering lymphotoxin beta receptor-alpha/beta heteromeric complex and a pharmaceutically acceptable carrier for therapy or reducing the advancement, severity or effects of neoplasia |
| 02/21/2006 | US7001597 Methods for altering fertility |
| 02/21/2006 | CA2216609C Production of antibodies using cre-mediated site-specific recombination |
| 02/21/2006 | CA2098959C Compounds and methods for the site-specific photoaffinity labelling of biomolecules |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/21/2006 | CA2032381C Viral agent |
| 02/16/2006 | WO2006017538A2 Hk1-binding proteins |
| 02/16/2006 | WO2006016692A1 Knockout nonhuman animal |
| 02/16/2006 | WO2006016644A1 Antibody and utilization of the same |
| 02/16/2006 | WO2006016380A2 A chimeric g protein based rabies vaccine |
| 02/16/2006 | WO2006016276A2 Therapeutic and diagnostic methods and compositions targeting 4ig-b7-h3 and its counterpart nk cell receptor |
| 02/16/2006 | WO2006015886A1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 02/16/2006 | WO2005118630A3 Peptides for the treatment of diabetes |
| 02/16/2006 | WO2005114218A3 Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule |
| 02/16/2006 | WO2005107803A3 Methods of determining the prognosis and treatment of subjects with lung cancer |
| 02/16/2006 | WO2005103084A3 Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof |
| 02/16/2006 | WO2005080432A3 Cdr-repaired antibodies |
| 02/16/2006 | WO2005077983A3 Modulating p38 kinase activity |
| 02/16/2006 | WO2005077981A3 Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES |
| 02/16/2006 | WO2005076012A3 Novel splice variants and methods of use thereof |
| 02/16/2006 | WO2005056575A3 INTEGRIN αIIbβ3 SPECIFIC ANTIBODIES AND PEPTIDES |
| 02/16/2006 | WO2005005455A3 Specific human antibodies |
| 02/16/2006 | WO2004091510A3 Recombinant il-9 antibodies and uses thereof |